Craig-Hallum Assumes Avadel Pharmaceuticals (AVDL) at Buy

July 28, 2022 8:18 AM EDT
Get Alerts AVDL Hot Sheet
Price: $21.64 --0%

Rating Summary:
    5 Buy, 10 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

Craig-Hallum analyst Robin Garner assumes coverage on Avadel Pharmaceuticals (NASDAQ: AVDL) with a Buy rating and a price target of $12.00.


For an analyst ratings summary and ratings history on Avadel Pharmaceuticals click here. For more ratings news on Avadel Pharmaceuticals click here.


Shares of Avadel Pharmaceuticals closed at $4.55 yesterday.


You May Also Be Interested In





Related Categories

Hot New Coverage, New Coverage